FDA Amends Animal Drug Regulations to Reflect Approval of Lasalocid Supplemental NADA Application

Summary

The Food and Drug Administration (FDA) is updating its animal drug regulations to reflect the approval of a supplemental new animal drug application (NADA) filed by Alpharma, Inc., which sets limits on lasalocid residues in poultry tissues.